Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:
Net Sales at Rs 12.86 crore in September 2024 down 13.67% from Rs. 14.89 crore in September 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.76 crore in September 2024 down 61.31% from Rs. 3.57 crore in September 2023.
EBITDA stands negative at Rs. 2.63 crore in September 2024 down 260.27% from Rs. 0.73 crore in September 2023.
Krebs Biochem shares closed at 88.03 on November 08, 2024 (NSE) and has given 30.51% returns over the last 6 months and 4.74% over the last 12 months.
Story continues below Advertisement
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 12.86 | 12.89 | 14.89 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 12.86 | 12.89 | 14.89 | | EXPENDITURE | | Consumption of Raw Materials | 1.03 | 0.37 | 0.63 | | Purchase of Traded Goods | -- | 0.04 | -- | | Increase/Decrease in Stocks | 1.39 | 0.85 | 1.43 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.39 | 4.25 | 4.09 | | Depreciation | 1.71 | 1.69 | 1.71 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 8.75 | 9.58 | 9.65 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.42 | -3.89 | -2.61 | | Other Income | 0.09 | 0.03 | 0.17 | | P/L Before Int., Excpt. Items & Tax | -4.34 | -3.85 | -2.44 | | Interest | 1.42 | 1.32 | 1.13 | | P/L Before Exceptional Items & Tax | -5.76 | -5.17 | -3.57 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.76 | -5.17 | -3.57 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -5.76 | -5.17 | -3.57 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.76 | -5.17 | -3.57 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.67 | -2.40 | -1.66 | | Diluted EPS | -2.67 | -2.40 | -1.66 | | EPS After Extra Ordinary | | Basic EPS | -2.67 | -2.40 | -1.66 | | Diluted EPS | -2.67 | -2.40 | -1.66 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
